Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00591942 · ClinicalTrials.gov registry record · NA

Outcome Evaluation of Ceramic Crowns Using Two Different Dental Cements

A NA study, sponsored by Clark Stanford.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT00591942 is a NA study that has completed, run by Clark Stanford. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00591942, a NA study, has completed, sponsored by Clark Stanford.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

The restoration of indirect partial and full coverage restorations in dentistry necessitates the use of a luting agent to act as a means of mechanical and potentially, chemical retention of the restoration. Upon the introduction of the first generation of glass Ionomer cements for use as a luting agent, an elevated short-term post operative hypersentivity was reported. In part, this adverse event was considered to be due to a desiccating effect of the cement as water is utilized in the setting reaction and thus a desiccation of the dentinal tubules was proposed as a potential mechanism leading to disruption of the neurosensory odontoblasts. Further materials development in the field of dental cement luting agents has lead to the introduction to the current market of resin formulations that have an alternative mechanism of setting. Consequently, there are anecdotal reports of a decrease in the incidence of post-operative sensitivity but no comparison with the effect of conventionally used dentin desensitizing agents as a part of the bonding process of the restoration. The purpose of this trial is a single blinded parallel design randomized clinical trial to evaluate the perceived incidence of post-operative sensitivity when full coverage all ceramic crowns or short-span three unit fixed partial dentures (dental bridge) is fabricated in the posterior part of the mouth. The dental crowns or bridges will be bonded with conventional glass ionomer cement or a Urethane dimethacrylate / Bis-GMA composite resin dental cement. Outcome measures will be both objective clinical criteria and the use of a calibrated pain survey instrument.

Interventions

  • DEVICE Full ceramic crowns or 3-unit fixed partial dentures.

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2004-11
Est. Completion 2009-12
Phase NA

Sponsor

Clark Stanford

2 total trials

What the Registry Record Tells You About NCT00591942

The ClinicalTrials.gov registry entry for NCT00591942 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clark Stanford, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Full ceramic crowns or 3-unit fixed partial dentures. is the first listed.

NCT00591942 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00591942 about?

NCT00591942 is a clinical study titled "Outcome Evaluation of Ceramic Crowns Using Two Different Dental Cements". The restoration of indirect partial and full coverage restorations in dentistry necessitates the use of a luting agent to act as a means of mechanical and potentially, chemical retention of the restoration. Upon the introduction of the first generation of glass Ionomer cements for use as a luting ag...

What is the current status of trial NCT00591942?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2004-11. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00591942?

The interventions under investigation include: Full ceramic crowns or 3-unit fixed partial dentures. (DEVICE).

Who is sponsoring clinical trial NCT00591942?

This trial is sponsored by Clark Stanford, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.